Digraph

2019-11 Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study
Faecal microbiota transplant better than antibiotics for treating superbug, says studyhttps://www.nutraingredients.com/Article/2019/11/07/Faecal-microbiota-transplant-better-than-antibiotics-for-treating-superbug-says-study
2019-11 Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort StudyFidaxomicin
Recurrent | Annals of Internal Medicine | American College of Physicianshttps://annals.org/aim/article-abstract/2754174/incidence-bloodstream-infections-length-hospital-stay-survival-patients-recurrent-clostridioides
2019-11 Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study

Showing topic

2019-11 Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study
Clostridioides difficile (C diff, CDI)